RecruitingNCT07143110

LUNG-ROLL: Treatment Patterns and Cost of Illness of Lung Cancer in Canada

Sponsor

AstraZeneca

Enrollment

60,000 participants

Start Date

Aug 20, 2025

Study Type

OBSERVATIONAL

Conditions

Lung Neoplasms

Summary

LUNG-ROLL is a retrospective cohort study that will describe the contemporary treatment patterns, prevalence and incidence, patient demographic and clinical characteristics, clinical outcomes, and healthcare resource use/costs for patients with lung cancer in Canada (specifically, Alberta and Ontario) using administrative data.

Eligibility

Min Age: 18 YearsMax Age: 130 Years

Inclusion Criteria3

Patients with lung cancer between January 1, 2018 and end of the Selection Period.
Patient is 18 years of age or older on diagnosis date.
Patient has at least 12 months of health insurance coverage prior to the diagnosis date.

Exclusion Criteria4

Diagnosed with any other cancer in the 5-year period prior to January 1, 2018.
Diagnosed with any other cancer concurrently (i.e., on the same date) as lung cancer diagnosis.
Invalid or incomplete records for key variables (e.g., missing year of diagnosis, missing cancer type).
Non-Ontario or non-Alberta resident on diagnosis date.